Total synthesis reveals potent anticancer properties in phaeocaulisin A analogs, indicating novel therapeutic potentials.
Guaianolide sesquiterpene natural products are of great biological and synthetic importance. Among them, phaeocaulisin A with a unique tetracyclic skeleton was isolated in 2013 and found to exhibit anticancer cell proliferation activity and anti-inflammatory activity. The first total synthesis of (-)-phaeocaulisin A was achieved by Procter and co-workers in 2022. Two years later, we reported a total synthesis of (±)-phaeocaulisin A. The key steps of our total synthesis include a novel palladium-catalyzed cyclopropanol ring-opening carbonylative esterification to access a key γ-ketoester, a regio- and stereo-selective aldol cyclization to build the 7-membered carbocycle, and a cascade ketalization/lactonization to construct the tetracyclic skeleton. This Synpact article reflects our journey toward (±)-phaeocaulisin A, which also led to the discovery of an analog with potent anticancer activity against triple negative or HER2+ breast cancer.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: